- Home
- IMMX vs IDN Comparison
IMMX vs IDN Comparison
Compare IMMX & IDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMX
- IDN
- Stock Information
- Founded
- IMMX 2014
- IDN 1994
- Country
- IMMX United States
- IDN United States
- Employees
- IMMX N/A
- IDN N/A
- Industry
- IMMX Medicinal Chemicals and Botanical Products
- IDN Computer Software: Prepackaged Software
- Sector
- IMMX Health Care
- IDN Technology
- Exchange
- IMMX Nasdaq
- IDN Nasdaq
- Market Cap
- IMMX 55.3M
- IDN 50.8M
- IPO Year
- IMMX 2021
- IDN 1999
- Fundamental
- Price
- IMMX $1.76
- IDN $2.65
- Analyst Decision
- IMMX Strong Buy
- IDN Buy
- Analyst Count
- IMMX 1
- IDN 3
- Target Price
- IMMX $7.00
- IDN $3.33
- AVG Volume (30 Days)
- IMMX 83.5K
- IDN 59.1K
- Earning Date
- IMMX 03-28-2025
- IDN 03-20-2025
- Dividend Yield
- IMMX N/A
- IDN N/A
- EPS Growth
- IMMX N/A
- IDN N/A
- EPS
- IMMX N/A
- IDN N/A
- Revenue
- IMMX N/A
- IDN $19,236,000.00
- Revenue This Year
- IMMX N/A
- IDN $2.09
- Revenue Next Year
- IMMX $600.00
- IDN $8.67
- P/E Ratio
- IMMX N/A
- IDN N/A
- Revenue Growth
- IMMX N/A
- IDN 5.22
- 52 Week Low
- IMMX $1.26
- IDN $1.67
- 52 Week High
- IMMX $3.80
- IDN $4.46
- Technical
- Relative Strength Index (RSI)
- IMMX 31.71
- IDN 48.32
- Support Level
- IMMX $1.85
- IDN $2.51
- Resistance Level
- IMMX $2.14
- IDN $2.70
- Average True Range (ATR)
- IMMX 0.12
- IDN 0.16
- MACD
- IMMX -0.02
- IDN -0.01
- Stochastic Oscillator
- IMMX 8.43
- IDN 36.84
About IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.
About IDN Intellicheck Inc.
Intellicheck Inc is a trusted industry leader in technology solutions that stop identity theft and fraud with real-time identification authentication and age verification. The company makes it possible for its clients to increase revenues, improve customer service, and increase operational efficiencies. Under the new direction, the company is focused on partnering with banks credit card issuers, and retailers to prevent fraud. It derives revenue through Sales of systems, subscription fees, Sale of software upgrades, and extended maintenance programs.